Methazolamide NEW
| Price | $50 |
| Package | 500mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-11-07 |
Product Details
| Product Name: Methazolamide | CAS No.: 554-57-4 |
| Purity: 99.77% | Supply Ability: 10g |
| Release date: 2025/11/07 |
Product Introduction
Bioactivity
| Name | Methazolamide |
| Description | Methazolamide (CL 8490) is a carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma. |
| In vitro | Methazolamide is a carbonic anhydrase inhibitor that inhibits hCA I (Ki: 50 nM), hCA II (Ki: 14 nM) and bCA IV (Ki: 36 nM) isoforms. |
| In vivo | Methazolamide is a carbonic anhydrase inhibitor that inhibits hCA I (Ki: 50 nM), hCA II (Ki: 14 nM) and bCA IV (Ki: 36 nM) isoforms. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : < 1 mg/mL (insoluble or slightly soluble) DMSO : 60 mg/mL (253.95 mM), Sonication is recommended. Ethanol : 3 mg/mL (12.7 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (8.46 mM), Sonication is recommended. |
| Keywords | pressure-lowering | Methazolamide | L-584601 | L 584601 | intraocular | Inhibitor | inhibit | hCAII | hCAI | glaucoma | disorders | CL-8490 | CL8490 | CarbonicAnhydrase | Carbonic Anhydrase | Carbonate dehydratase | bCAIV |
| Inhibitors Related | Benzenesulfonamide | Urea | Cyclamic acid sodium | Hydrochlorothiazide | Orthanilamide | Tioxolone | Zonisamide | Histone acetyltransferase p300 Inhibitor 4c | EMAC10101d | pNNP | Levosimendan | Trichlormethiazide |
| Related Compound Libraries | Failed Clinical Trials Compound Library | Bioactive Compound Library | Drug-induced Liver Injury (DILI) Compound Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $50.00/500mg |
VIP6Y
|
TargetMol Chemicals Inc.
|
2025-11-04 | |
| $48.00/100mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-04-27 | |
| $67.00/1kg |
Hebei Fengjia New Material Co., Ltd
|
2024-08-22 | ||
| $9.00/1kg |
Hebei baicao biology science and technology co., ltd
|
2022-04-01 | ||
| $22.00/1KG |
Hong Kong Tiansheng New Material Trading Co., Ltd
|
2022-01-07 | ||
| $15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-11 | ||
| $7.00/1kg |
VIP8Y
|
Career Henan Chemical Co
|
2018-12-21 | |
| $28.99/1KG |
Hong Kong Tiansheng New Material Trading Co., Ltd
|
2021-12-28 | ||
| $15.00/1KG |
Zhuozhou Wenxi import and Export Co., Ltd
|
2021-07-09 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY